- Report
- January 2025
- 150 Pages
Global
From €5447EUR$5,950USD£4,629GBP
- Report
- December 2024
- 120 Pages
Global
From €5447EUR$5,950USD£4,629GBP
- Report
- December 2024
- 150 Pages
Global
From €5447EUR$5,950USD£4,629GBP
- Report
- April 2025
- 89 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- April 2025
- 89 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- April 2025
- 89 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- April 2025
- 93 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- April 2025
- 174 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- April 2025
- 194 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- April 2025
- 192 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- April 2025
- 279 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- April 2025
- 465 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- April 2025
- 179 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- March 2025
- 241 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- April 2025
- 175 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- April 2025
- 250 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- April 2025
- 250 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- April 2025
- 250 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- April 2025
- 250 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- April 2025
- 250 Pages
Global
From €4110EUR$4,490USD£3,493GBP

The Blood Cell market is a subset of the biotechnology industry that focuses on the development of products and services related to the study and manipulation of blood cells. This includes the production of blood cell-based therapeutics, such as monoclonal antibodies, as well as the development of diagnostic tests and treatments for blood-related diseases. Blood cell research is also used to develop treatments for cancer, autoimmune diseases, and other conditions.
The Blood Cell market is a rapidly growing sector of the biotechnology industry, with new products and services being developed to meet the needs of patients and healthcare providers. Companies in this market are focused on developing innovative technologies and treatments to improve patient outcomes and reduce healthcare costs.
Some of the companies in the Blood Cell market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Regeneron Pharmaceuticals. Show Less Read more